China Cord Blood Corp down (U.S.)$0.50

China Cord Blood Corp closed sharply lower Thursday, dropping (U.S.)$0.50 or 3.83% to (U.S.)$12.54. Over the last five days, shares have gained 4.24% and 104.90% year to date. Shares have outperformed the S&P 500 by 138.94% during the last year.

Key company metrics

Open(U.S.) $13.03

Previous close(U.S.) $13.04

High(U.S.) $13.05

Low(U.S.) $12.53

Bid / Ask-- / --

YTD % change+104.90%

Volume286,142

Average volume (10-day)417,518

Average volume (1-month)487,769

Average volume (3-month)500,956

52-week range(U.S.) $4.27 to (U.S.) $13.22

Beta0.92

Trailing P/E52.68×

P/E 1 year forwardNegative, not meaningful

Forward PEGNegative, not meaningful

Indicated annual dividend--

Dividend yield0.00%

Trailing EPS(U.S.) $0.24

Updated August 17 4:02 PM EDT. Delayed by at least 15 minutes.

Key company metrics

Open(U.S.) $13.03

Previous close(U.S.) $13.04

High(U.S.) $13.05

Low(U.S.) $12.53

Bid / Ask-- / --

YTD % change+104.90%

Volume286,142

Average volume (10-day)417,518

Average volume (1-month)487,769

Average volume (3-month)500,956

52-week range(U.S.) $4.27 to (U.S.) $13.22

Beta0.92

Trailing P/E52.68×

P/E 1 year forwardNegative, not meaningful

Forward PEGNegative, not meaningful

Indicated annual dividend--

Dividend yield0.00%

Trailing EPS(U.S.) $0.24

Updated August 17 4:02 PM EDT. Delayed by at least 15 minutes.

About

China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical

Continue reading

cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.

Restrictions

All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for any actions taken in reliance on such content. ‘Thomson Reuters’ and the Thomson Reuters logo are trademarks of Thomson Reuters and its affiliated companies.